General Information of Drug Combination (ID: DC9X6C6)

Drug Combination Name
Vinflunine Hepzato
Indication
Disease Entry Status REF
High grade ovarian serous adenocarcinoma Investigative [1]
Component Drugs Vinflunine   DMTJAEP Hepzato   DM2AZPP
Small molecular drug N.A.
High-throughput Screening Result Testing Cell Line: OVCAR-5
Zero Interaction Potency (ZIP) Score: 0.23
Bliss Independence Score: 5.5
Loewe Additivity Score: 4.7
LHighest Single Agent (HSA) Score: 1.91

Test Results of This Drug Combination in Other Disease Systems

Indication DrugCom ID Cell Line Status REF
Adult acute myeloid leukemia DCASY1N HL-60(TB) Investigative [4]
Carcinoma DCFLQAD MCF7 Investigative [5]
Adenocarcinoma DCLOPGX HT29 Investigative [1]
Adenocarcinoma DCBFZHO HCT-15 Investigative [1]
------------------------------------------------------------------------------------

References

1 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125976
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 ClinicalTrials.gov (NCT05022901) An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma. U.S.National Institutes of Health.
4 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125966
5 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1126165